Literature DB >> 26861426

Actinic Prurigo.

Alma Angélica Rodríguez-Carreón1, Erika Rodríguez-Lobato2, Georgina Rodríguez-Gutiérrez2, Juan Carlos Cuevas-González2, Alexandra Mancheno-Valencia2, Martha Patricia Solís-Arias2, María Elisa Vega-Memije2, María Teresa Hojyo-Tomoka2, Luciano Domínguez-Soto2.   

Abstract

Actinic prurigo is an idiopathic photodermatosis that affects the skin, as well as the labial and conjunctival mucosa in indigenous and mestizo populations of Latin America. It starts predominantly in childhood, has a chronic course, and is exacerbated with solar exposure. Little is known of its pathophysiology, including the known mechanisms of the participation of HLA-DR4 and an abnormal immunologic response with increase of T CD4+ lymphocytes. The presence of IgE, eosinophils, and mast cells suggests that it is a hypersensitivity reaction (likely type IVa or b). The diagnosis is clinical, and the presence of lymphoid follicles in the mucosal histopathologic study of mucosa is pathognomonic. The best available treatment to date is thalidomide, despite its secondary effects.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26861426

Source DB:  PubMed          Journal:  Skinmed        ISSN: 1540-9740


  2 in total

1.  Risk factors associated with actinic prurigo: a case control study.

Authors:  Juan Carlos Cuevas-Gonzalez; María Elisa Vega-Memíje; Socorro Aída Borges-Yáñez; Erika Rodríguez-Lobato
Journal:  An Bras Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.896

2.  Skin Disease in the Tropics and the Lessons that can be Learned from Leprosy and Other Neglected Diseases.

Authors:  Roderick J Hay
Journal:  Acta Derm Venereol       Date:  2020-04-20       Impact factor: 3.875

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.